Sanofi pharmaceuticals now owns Genzyme, manufacturer of thymoglobulin and alemtuzumab
Sanofi pharmaceuticals now owns Genzyme, manufacturer of thymoglobulin and alemtuzumab. were recognized. Muromonab-CD3 was associated with increased NHL (aIRR=1.37, Arglabin 95% CI 1.06C1.76). Alemtuzumab was associated with increased NHL (aIRR=1.79,…